Cutler Group LP Fulgent Genetics, Inc. Transaction History

Cutler Group LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$26.74 - $40.81 $2,834 - $4,325	106 New	106 $2,000
Q4 2022 Feb 07, 2023	SELL	$29.23 - $40.28 $151,820 - $209,214	-5,194 Reduced 97.36%	141 $4,000
Q3 2022 Oct 25, 2022	BUY	$37.92 - $63.74 $198,662 - $333,933	5,239 Added 5457.29%	5,335 $203,000
Q2 2022 Aug 04, 2022	SELL	$47.98 - $62.75 $24,709 - $32,316	-515 Reduced 84.29%	96 $5,000
Q1 2022 Apr 14, 2022	SELL	$49.85 - $96.11 $16,649 - $32,100	-334 Reduced 35.34%	611 $38,000
Q4 2021 Jan 18, 2022	BUY	$77.3 - $105.0 $70,111 - $95,235	907 Added 2386.84%	945 $95,000
Q3 2021 Oct 26, 2021	SELL	$74.87 - $110.87 $515,779 - $763,783	-6,889 Reduced 99.45%	38 $3,000
Q1 2021 Apr 26, 2021	SELL	$59.3 - $183.85 $23,186 - $71,885	-391 Reduced 5.34%	6,927 $669,000
Q4 2020 Jan 21, 2021	BUY	$31.01 - $52.1 $220,729 - $370,847	7,118 Added 3559.0%	7,318 $381,000
Q3 2020 Oct 27, 2020	BUY	$15.89 - $50.51 $3,178 - $10,102	200 New	200 $8,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.